HealthWall Street Journal1 day ago
Peak Rock Acquires Asembia For Specialty Drugs
1 min read
Exclusive reports state that Peak Rock Capital acquired specialty drug company Asembia to capitalize on a growing market boom. The deal targets high-value pharmaceutical segments within the broader healthcare industry landscape.
Level
Hype check
Tap to vote and see what everyone thinks.
